Partnering with NCPIE Part of FDA Effort to Address the Misuse and Abuse of Opioids

•The FDA has embarked on a multi-pronged and targeted approach aimed at combating misuse, abuse and addiction at critical points in the lifecycle of an opioid product, from development through use. The task force’s multi-pronged approach is outlined below. Opioid Labeling Prescriber Education Patient Education Exploring Innovative Packaging/Storage to Prevent Abuse Encouraging the Development of Products that Treat Abuse and Overdose Drug Development As a component of its patient education effort, FDA also partners with outside organizations to help educate patients about the best uses of opioids, participating in a drug abuse campaign sponsored by and is a member of the National Council on Patient Information and Education, which is running a campaign targeting teens and college students on prescription drug abuse.